Insider Transactions in Q4 2025 at Good Rx Holdings, Inc. (GDRX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2025
|
Ronald E Bruehlman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
21,691
+16.34%
|
-
|
|
Nov 08
2025
|
Romin Nabiey Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,531
-2.87%
|
$13,593
$3.11 P/Share
|
|
Nov 08
2025
|
Romin Nabiey Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,662
+7.42%
|
-
|
|
Nov 02
2025
|
Trevor Bezdek Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,530
+17.32%
|
-
|
|
Oct 31
2025
|
Scott Wagner Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,065
+1.63%
|
-
|
|
Oct 26
2025
|
Douglas Joseph Hirsch Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,521
+8.13%
|
-
|
|
Oct 15
2025
|
Spectrum Equity Vii, L.P. |
SELL
Open market or private sale
|
Indirect |
23,771
-100.0%
|
$95,084
$4.0 P/Share
|
|
Oct 14
2025
|
Spectrum Equity Vii, L.P. |
SELL
Other acquisition or disposition
|
Indirect |
8,881,362
-100.0%
|
-
|
|
Oct 14
2025
|
Spectrum Equity Vii, L.P. |
BUY
Conversion of derivative security
|
Indirect |
8,905,133
+50.0%
|
-
|